Fan W - Search Results

1

Time to untreatable progression is an appropriate surrogate endpoint for overall survival in patients with hepatocellular carcinoma after transarterial chemoembolization.

Wang H, Li B, Wang Y, Zhang J, Wu Y, Fan W, Li J. Wang H, et al. Among authors: fan w. J Cancer Res Ther. 2020;16(2):301-308. doi: 10.4103/jcrt.JCRT_898_19. J Cancer Res Ther. 2020. PMID: 32474517 Free article.

2

[Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].

Fan WZ, Yang JY, Lü MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP. Fan WZ, et al. Zhonghua Yi Xue Za Zhi. 2011 Aug 23;91(31):2190-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22094036 Clinical Trial. Chinese.

3

[Transcriptional targeting gene therapy of double suicide gene driven by hTERT promoter in hepatic carcinoma].

Fan WZ, Yang JY, Chen W, Huang YH, Wang Y, Zhang YQ, Li JP. Fan WZ, et al. Zhonghua Yi Xue Za Zhi. 2011 Nov 22;91(43):3080-5. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22333065 Chinese.

4

Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats.

Wang Y, Lian F, Li J, Fan W, Xu H, Yang X, Liang L, Chen W, Yang J. Wang Y, et al. Among authors: fan w. J Transl Med. 2012 Jun 26;10:133. doi: 10.1186/1479-5876-10-133. J Transl Med. 2012. PMID: 22735033 Free PMC article.

5

[The analysis of the efficacy and safety of combined transarterial chemoembolization with sorafenib in patients with large hepatocellular carcinoma].

Zhang YQ, Yang JY, Wang Y, Huang YH, Fan WZ, Li JP. Zhang YQ, et al. Zhonghua Yi Xue Za Zhi. 2013 Apr 2;93(13):987-91. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23886261 Chinese.

6

OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma.

Jin Y, Chen JN, Feng ZY, Zhang ZG, Fan WZ, Wang Y, Li JP. Jin Y, et al. PLoS One. 2014 Feb 3;9(2):e87930. doi: 10.1371/journal.pone.0087930. eCollection 2014. PLoS One. 2014. PMID: 24498405 Free PMC article.

7

The expression of Survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma.

Jin Y, Chen J, Feng Z, Fan W, Wang Y, Li J, Tong D. Jin Y, et al. Among authors: fan w. Tumour Biol. 2014 Oct;35(10):9905-10. doi: 10.1007/s13277-014-2279-0. Epub 2014 Jul 5. Tumour Biol. 2014. PMID: 24996542

8

Combination of individualized local control and target-specific agent to improve unresectable liver cancer managements: a matched case-control study.

Li J, Zhang F, Yang J, Zhang Y, Wang Y, Fan W, Huang Y, Wang W, Ran H, Ke S. Li J, et al. Among authors: fan w. Target Oncol. 2015 Jun;10(2):287-95. doi: 10.1007/s11523-014-0338-5. Epub 2014 Oct 8. Target Oncol. 2015. PMID: 25293575

9

[An analysis of clinical factors in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization complicated with diabetes].

Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Fan W, et al. Zhonghua Yi Xue Za Zhi. 2014 Sep 9;94(33):2562-5. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25511483 Chinese.

10

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.

Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Fan W, et al. PLoS One. 2015 Mar 5;10(3):e0119312. doi: 10.1371/journal.pone.0119312. eCollection 2015. PLoS One. 2015. PMID: 25742141 Free PMC article.

11

Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response.

Zhang Y, Fan W, Zhu K, Lu L, Fu S, Huang J, Wang Y, Yang J, Huang Y, Yao W, Li J. Zhang Y, et al. Among authors: fan w. Oncotarget. 2015 Sep 15;6(27):24550-9. doi: 10.18632/oncotarget.4076. Oncotarget. 2015. PMID: 26093084 Free PMC article.

12

Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.

Zhang Y, Fan W, Wang Y, Lu L, Fu S, Yang J, Huang Y, Yao W, Li J. Zhang Y, et al. Among authors: fan w. Oncologist. 2015 Dec;20(12):1417-24. doi: 10.1634/theoncologist.2015-0196. Epub 2015 Oct 7. Oncologist. 2015. PMID: 26446238 Free PMC article. Clinical Trial.

13

Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efficacy.

Fan W, Niu L, Wang Y, Zhang Y, Yao X, Tan G, Yang J, Li J. Fan W, et al. Oncotarget. 2016 Jul 5;7(27):42639-42649. doi: 10.18632/oncotarget.9476. Oncotarget. 2016. PMID: 27223071 Free PMC article.

14

Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.

Wang Y, Cui W, Fan W, Zhang Y, Yao W, Huang K, Li J. Wang Y, et al. Among authors: fan w. Oncotarget. 2016 Aug 16;7(33):53911-53920. doi: 10.18632/oncotarget.10116. Oncotarget. 2016. PMID: 27322076 Free PMC article.

15

Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.

Zhang Y, Huang G, Wang Y, Liang L, Peng B, Fan W, Yang J, Huang Y, Yao W, Li J. Zhang Y, et al. Among authors: fan w. Oncologist. 2016 Dec;21(12):1442-1449. doi: 10.1634/theoncologist.2016-0094. Epub 2016 Aug 2. Oncologist. 2016. PMID: 27486202 Free PMC article.

16

Initial Experience: Alleviation of Pain with Percutaneous CT-Guided Cryoablation for Recurrent Retroperitoneal Soft-Tissue Sarcoma.

Fan WZ, Niu LZ, Wang Y, Yao XH, Zhang YQ, Tan GS, Yang JY, Li JP. Fan WZ, et al. J Vasc Interv Radiol. 2016 Dec;27(12):1798-1805. doi: 10.1016/j.jvir.2016.06.034. Epub 2016 Sep 9. J Vasc Interv Radiol. 2016. PMID: 27617909

17

The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.

Cui W, Fan W, Lu M, Zhang Y, Yao W, Li J, Wang Y. Cui W, et al. Among authors: fan w. BMC Cancer. 2017 Apr 24;17(1):288. doi: 10.1186/s12885-017-3278-5. BMC Cancer. 2017. PMID: 28438130 Free PMC article.

18

Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.

Cui W, Wang Y, Fan W, Lu M, Zhang Y, Yao W, Li J. Cui W, et al. Among authors: fan w. Int J Hyperthermia. 2017 Nov;33(7):853-861. doi: 10.1080/02656736.2017.1309580. Epub 2017 Apr 10. Int J Hyperthermia. 2017. PMID: 28540797 Free article.

19

Feasibility and Efficacy of Microwave Ablation Combined with Iodine-125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience.

Lu M, Yao W, Zhang T, Fan W, Zhong Z, Li J, Zhang F. Lu M, et al. Among authors: fan w. Oncologist. 2017 Dec;22(12):1500-1505. doi: 10.1634/theoncologist.2016-0499. Epub 2017 Jul 12. Oncologist. 2017. PMID: 28701568 Free PMC article.

20

Decreased WWOX expression promotes angiogenesis in osteosarcoma.

Wen J, Xu Z, Li J, Zhang Y, Fan W, Wang Y, Lu M, Li J. Wen J, et al. Among authors: fan w. Oncotarget. 2017 Apr 15;8(37):60917-60932. doi: 10.18632/oncotarget.17126. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977834 Free PMC article.

21

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin.

Cui W, Fan W, Zhang Q, Wen J, Huang Y, Yang J, Li J, Wang Y. Cui W, et al. Among authors: fan w. Oncotarget. 2017 Mar 16;8(45):79165-79174. doi: 10.18632/oncotarget.16298. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108296 Free PMC article.

22

Is Emergency Transcatheter Hepatic Arterial Embolization Suitable for Spontaneously Ruptured Hepatocellular Carcinoma in Child-Pugh C Cirrhosis?

Fan WZ, Zhang YQ, Yao W, Wang Y, Tan GS, Huang YH, Yang JY, Li JP. Fan WZ, et al. J Vasc Interv Radiol. 2018 Mar;29(3):404-412.e3. doi: 10.1016/j.jvir.2017.09.022. Epub 2017 Dec 14. J Vasc Interv Radiol. 2018. PMID: 29249595

23

Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysis.

Yao W, Lu M, Fan W, Huang J, Gu Y, Gao F, Wang Y, Li J, Zhu Z. Yao W, et al. Among authors: fan w. Int J Hyperthermia. 2018 Dec;34(8):1329-1336. doi: 10.1080/02656736.2018.1434901. Epub 2018 Feb 12. Int J Hyperthermia. 2018. PMID: 29378462 Free article.

24

Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor Resection.

Cui W, Fan W, Lu M, Zhang Y, Yao W, Wang Y, Li J. Cui W, et al. Among authors: fan w. Oncol Res Treat. 2018;41(1-2):22-28. doi: 10.1159/000481096. Epub 2018 Jan 23. Oncol Res Treat. 2018. PMID: 29393244

25

A novel mechanism of the M1-M2 methionine adenosyltransferase switch-mediated hepatocellular carcinoma metastasis.

Wang R, Jin Y, Yao XH, Fan W, Zhang J, Cao Y, Li J. Wang R, et al. Among authors: fan w. Mol Carcinog. 2018 Sep;57(9):1201-1212. doi: 10.1002/mc.22836. Epub 2018 May 27. Mol Carcinog. 2018. PMID: 29749642

26

Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis.

Yao W, Meng Y, Lu M, Fan W, Huang J, Li J, Zhu Z. Yao W, et al. Among authors: fan w. Cancer Commun (Lond). 2018 Apr 27;38(1):14. doi: 10.1186/s40880-018-0275-2. Cancer Commun (Lond). 2018. PMID: 29764483 Free PMC article.

27

Large hepatocellular carcinomas: treatment with transarterial chemoembolization alone or in combination with percutaneous cryoablation.

Cui W, Fan W, Huang K, Wang Y, Lu M, Yao W, Li J. Cui W, et al. Among authors: fan w. Int J Hyperthermia. 2018;35(1):239-245. doi: 10.1080/02656736.2018.1493235. Epub 2018 Sep 10. Int J Hyperthermia. 2018. PMID: 30200796 Free article.

28

A meta-analysis of the efficacy and safety of iodine [¹³¹I] metuximab infusion combined with TACE for treatment of hepatocellular carcinoma.

Fan W, Wu Y, Lu M, Yao W, Cui W, Zhao Y, Wang Y, Li J. Fan W, et al. Clin Res Hepatol Gastroenterol. 2019 Aug;43(4):451-459. doi: 10.1016/j.clinre.2018.09.006. Epub 2018 Oct 19. Clin Res Hepatol Gastroenterol. 2019. PMID: 30348520

29

Comparison of α-Fetoprotein Criteria and Modified Response Evaluation Criteria in Solid Tumors for the Prediction of Overall Survival of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization.

Zhang YQ, Jiang LJ, Wen J, Liu DM, Huang GH, Wang Y, Fan WZ, Li JP. Zhang YQ, et al. J Vasc Interv Radiol. 2018 Dec;29(12):1654-1661. doi: 10.1016/j.jvir.2018.07.031. Epub 2018 Nov 3. J Vasc Interv Radiol. 2018. PMID: 30396842

30

Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer.

Huang B, Wang H, Lin H, Yao Z, Zheng J, Fan W, Qiu S, Chen L, Chen J. Huang B, et al. Among authors: fan w. J Cancer Res Clin Oncol. 2019 Feb;145(2):487-494. doi: 10.1007/s00432-018-2811-5. Epub 2018 Dec 11. J Cancer Res Clin Oncol. 2019. PMID: 30539282 Clinical Trial.

31

Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.

Lian F, Chen W, Liu Y, Shen L, Fan W, Cui W, Zhao Y, Li J, Wang Y. Lian F, et al. Among authors: fan w. J Cancer Res Clin Oncol. 2019 Jun;145(6):1625-1633. doi: 10.1007/s00432-019-02900-8. Epub 2019 Mar 21. J Cancer Res Clin Oncol. 2019. PMID: 30900154

32

Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma.

Wu J, Huang WJ, Xi HL, Liu LY, Wang ST, Fan WZ, Peng BG. Wu J, et al. Aging (Albany NY). 2019 Jun 4;11(11):3432-3444. doi: 10.18632/aging.101981. Aging (Albany NY). 2019. PMID: 31163018 Free PMC article.

33

Gefitinib with or without Transarterial Infusion Chemotherapy (Cisplatin) for Large Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations.

Zhang YQ, Jiang LJ, Jiang SX, Xu YF, Zhou BB, Huang GH, Liu DM, Wang Y, Fan WZ, Li JP, Wang B. Zhang YQ, et al. J Vasc Interv Radiol. 2019 Jul;30(7):1004-1012. doi: 10.1016/j.jvir.2018.12.705. Epub 2019 Jun 4. J Vasc Interv Radiol. 2019. PMID: 31171399

34

Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

Wu Y, Fan W, Xue M, Zhong B, Zhang S, Wang Y, Yao W, Zhao Y, Li J. Wu Y, et al. Among authors: fan w. Oncologist. 2019 Dec;24(12):e1489-e1495. doi: 10.1634/theoncologist.2018-0669. Epub 2019 Jun 27. Oncologist. 2019. PMID: 31249138 Free PMC article.

35

Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization.

Tian M, Zhang X, Huang G, Fan W, Li J, Zhang Y. Tian M, et al. Among authors: fan w. Abdom Radiol (NY). 2019 Oct;44(10):3304-3311. doi: 10.1007/s00261-019-02116-x. Abdom Radiol (NY). 2019. PMID: 31250181

36

Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.

Fan W, Yuan G, Fan H, Li F, Wu Y, Zhao Y, Yao W, Wang Y, Xue M, Yang J, Li J. Fan W, et al. Among authors: fan h. Clin Ther. 2019 Aug;41(8):1463-1476. doi: 10.1016/j.clinthera.2019.04.036. Epub 2019 Jul 11. Clin Ther. 2019. PMID: 31303279

37

Apatinib for Patients With Sorafenib-Refractory Advanced Hepatitis B Virus Related Hepatocellular Carcinoma: Results of a Pilot Study.

Zhang Y, Fan W, Wang Y, Huang G, Li J. Zhang Y, et al. Among authors: fan w. Cancer Control. 2019 Jan-Dec;26(1):1073274819872216. doi: 10.1177/1073274819872216. Cancer Control. 2019. PMID: 31466465 Free PMC article.

38

Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma.

Xue M, Wu Y, Fan W, Guo J, Wei J, Wang H, Tan J, Wang Y, Yao W, Zhao Y, Li J. Xue M, et al. Among authors: fan w. Cancer Res Treat. 2020 Jul;52(3):925-937. doi: 10.4143/crt.2019.533. Epub 2020 Mar 30. Cancer Res Treat. 2020. PMID: 32229792 Free PMC article.

39

Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Wang H, Lin C, Fan W, Zhang J, Zhang Y, Yao W, Li J. Wang H, et al. Among authors: fan w. Cancer Manag Res. 2020 May 14;12:3433-3444. doi: 10.2147/CMAR.S245396. eCollection 2020. Cancer Manag Res. 2020. PMID: 32523374 Free PMC article.

40

The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.

Zhang Y, Miao H, Xie W, Jiang S, Song Z, Huang G, Fan W, Wang Y, Li J, Chen Y. Zhang Y, et al. Among authors: fan w. Eur Radiol. 2021 Jan;31(1):232-243. doi: 10.1007/s00330-020-07078-z. Epub 2020 Jul 29. Eur Radiol. 2021. PMID: 32728770

41

Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma.

Zhang Y, Huang G, Miao H, Song Z, Zhang X, Fan W, Wang Y, Li J, Chen Y. Zhang Y, et al. Among authors: fan w. Ther Adv Med Oncol. 2020 Jul 23;12:1758835920937422. doi: 10.1177/1758835920937422. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32754228 Free PMC article.

42

Unresectable Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Combined With Microwave Ablation vs. Combined With Cryoablation.

Wei J, Cui W, Fan W, Wang Y, Li J. Wei J, et al. Among authors: fan w. Front Oncol. 2020 Aug 7;10:1285. doi: 10.3389/fonc.2020.01285. eCollection 2020. Front Oncol. 2020. PMID: 32850395 Free PMC article.

43

High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39⁺CD8⁺ T cells.

Liu T, Tan J, Wu M, Fan W, Wei J, Zhu B, Guo J, Wang S, Zhou P, Zhang H, Shi L, Li J. Liu T, et al. Among authors: fan w. Gut. 2021 Oct;70(10):1965-1977. doi: 10.1136/gutjnl-2020-322196. Epub 2020 Dec 1. Gut. 2021. PMID: 33262196 Free PMC article.

44

The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma.

Ke L, Shen R, Fan W, Hu W, Shen S, Li S, Kuang M, Liang L, Li J, Peng B, Hua Y. Ke L, et al. Among authors: fan w. Ann Transl Med. 2020 Nov;8(21):1402. doi: 10.21037/atm-20-2420. Ann Transl Med. 2020. PMID: 33313147 Free PMC article.

45

Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway.

Zhu B, Wu Y, Niu L, Yao W, Xue M, Wang H, Yang J, Li J, Fan W. Zhu B, et al. Among authors: fan w. Front Oncol. 2020 Dec 15;10:574383. doi: 10.3389/fonc.2020.574383. eCollection 2020. Front Oncol. 2020. PMID: 33384953 Free PMC article.

46

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy.

Yao W, Xue M, Lu M, Wang Y, Zhao Y, Wu Y, Fan W, Li J. Yao W, et al. Among authors: fan w. Front Oncol. 2020 Dec 17;10:574668. doi: 10.3389/fonc.2020.574668. eCollection 2020. Front Oncol. 2020. PMID: 33425729 Free PMC article.

47

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.

Fan W, Guo J, Zhu B, Wang S, Yu L, Huang W, Fan H, Li F, Wu Y, Zhao Y, Wang Y, Xue M, Wang H, Li J. Fan W, et al. Among authors: fan h. Eur Radiol. 2021 Nov;31(11):8291-8301. doi: 10.1007/s00330-021-07834-9. Epub 2021 Apr 24. Eur Radiol. 2021. PMID: 33893536 Free PMC article.

48

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression.

Zou X, Fan W, Xue M, Li J. Zou X, et al. Among authors: fan w. Cancer Manag Res. 2021 May 18;13:4013-4029. doi: 10.2147/CMAR.S304591. eCollection 2021. Cancer Manag Res. 2021. PMID: 34040442 Free PMC article.

49

Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective study.

Xue M, Wu Y, Zhu B, Zou X, Fan W, Li J. Xue M, et al. Among authors: fan w. Am J Cancer Res. 2021 Dec 15;11(12):6107-6118. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018245 Free PMC article.

50

A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.

Tang Y, Wu Y, Xue M, Zhu B, Fan W, Li J. Tang Y, et al. Among authors: fan w. J Oncol. 2022 Jan 24;2022:3822773. doi: 10.1155/2022/3822773. eCollection 2022. J Oncol. 2022. PMID: 35111225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,502 results

Search Page